Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. (SOMX) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 588 transactions totaling $41.6M, demonstrating a bearish sentiment with -$31.6M in net insider flow. The most recent transaction on Mar 6, 2013 involved a transaction of 70,388 shares valued at $0.
SOMX Insider Activity Summary
Who Is Buying SOMX Stock?
No significant insider buying has been recorded for SOMX in the recent period.
Who Is Selling SOMX Stock?
No significant insider selling has been recorded for SOMX in the recent period.
Is Somaxon Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SOMX is bearish with an Insider Alignment Score of 12/100 and a net flow of -$31.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SOMX Frequently Asked Questions
Understanding SOMX Insider Activity
Insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading SOMX stock, having executed 588 transactions in the past 90 days. The most active insider is Daniel K. Turner III (Executive), who has made 1 transactions totaling $9.6M.
Related Tools
Track Somaxon Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at SOMX file new Form 4 transactions